Skip to main content

Table 2 Analysis of overall survival by VeriStrat classification and treatment

From: The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

Covariate

Group

Cox PH

p value

Log Rank

p value

VeriStrat

Good

0.0002

0.0001

Poor

Treatment

Erlotinib

0.6043

0.5985

Chemotherapy

Erlotinib

Good

< 0.0001

< 0.0001

Poor

Chemotherapy

Good

0.2556

0.2520

Poor

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us